Work

Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients

Year: 2015

Type: article

Source: Repositorio Institucional E-DocUR (Universidad Del Rosario)

DOI: 10.1007/s00520-015-2712-y

Authors: Anne Sofie Brems-Eskildsen, Soeren Linnet, Adam Andrzej Luczak, Henrik Anker Nielsen, Peter Michael Vestlev, Brita B. Jensen, T. Hilling, Trine Dongsgaard, C. B. Jensen, J. Neimann, Ann‐Britt Nygaard, Sven Tyge Langkjer

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2247147336

FWCI: 0.104

Cites:

Cited by: 1

Related to: 10